Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jackson

Showing results (411-420 of 517) with videos related to

Pageof 52
Sort By:
Journal of Neurochemistry|February 24, 2001
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's diseaseS Przedborski, Q Chen, M Vila, et al.
Clinical Prostate Cancer|October 14, 2004
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancerWilliam R Berry, James W Hathorn, Shaker R Dakhil, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in manW E Nicholson, G S DeCherney, R V Jackson, et al.
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Journal of Neuroendocrinology|June 20, 2001
The insulin hypoglycemia test: hypoglycemic criteria and reproducibilityE J Nye, J E Grice, G I Hockings, et al.
Immunopharmacology and Immunotoxicology|December 14, 2007
Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone lossCharles A Lunn, Jay Fine, Alberto Rojas-Triana, et al.
Nature Medicine|December 2, 1999
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson diseaseG T Liberatore, V Jackson-Lewis, S Vukosavic, et al.
Clinical Endocrinology|March 16, 2002
Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion testsE J Nye, J E Grice, G I Hockings, et al.
The Journal of Pain|November 18, 2008
Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to homeBenjamin H Lee, Christoph U Lehmann, Eric V Jackson, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjectsW R Sheldon, C R DeBold, W S Evans, et al.
Pageof 52

Showing results (411-420 of 517) with videos related to

Sort By:
Pageof 52
Journal of Neurochemistry|February 24, 2001
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's diseaseS Przedborski, Q Chen, M Vila, et al.
Clinical Prostate Cancer|October 14, 2004
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancerWilliam R Berry, James W Hathorn, Shaker R Dakhil, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in manW E Nicholson, G S DeCherney, R V Jackson, et al.
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Journal of Neuroendocrinology|June 20, 2001
The insulin hypoglycemia test: hypoglycemic criteria and reproducibilityE J Nye, J E Grice, G I Hockings, et al.
Immunopharmacology and Immunotoxicology|December 14, 2007
Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone lossCharles A Lunn, Jay Fine, Alberto Rojas-Triana, et al.
Nature Medicine|December 2, 1999
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson diseaseG T Liberatore, V Jackson-Lewis, S Vukosavic, et al.
Clinical Endocrinology|March 16, 2002
Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion testsE J Nye, J E Grice, G I Hockings, et al.
The Journal of Pain|November 18, 2008
Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to homeBenjamin H Lee, Christoph U Lehmann, Eric V Jackson, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjectsW R Sheldon, C R DeBold, W S Evans, et al.
Pageof 52